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Summary
Symptomatic hypogammaglobulinaemia in children younger than 2 years 
of age was studied to rule out a primary immunodeficiency. Thirty-four 
patients were referred to the Immunology Service to study the hypogamma- 
globulinaemia-associated clinical picture. Food allergy was documented in 
10 patients by personal and familial history, presence of specific immuno­
globulin E (IgE) and elevated total serum IgE levels. Coeliac disease and 
human immunodeficiency virus infection were also ruled out. Protein loss 
through stools was assessed by clearance of al -antitrypsin (AAT). Serum 
immunoglobulin levels were determined by nephelometry and functional 
antibodies were studied by enzyme-linked immunosorbent assay. The cellu­
lar immune response was assessed by in vitro lymphocyte proliferation in 
response to mitogens and cell subsets were analysed by flow cytometry. In 
five patients of the 10 patients we suspected a protein loss through the 
mucosa. Four of these five patients showed an increased AAT and the other 
showed an extensive cutaneous lesion. Immunological studies revealed 
normal antibody function, in vitro lymphoproliferative responses and cell 
numbers in four of the 5 patients. One patient showed abnormally low 
numbers of CD4+ T cells as well as a defective proliferative response to mit­
ogens. After diagnosis of cow milk allergy, milk was replaced with infant 
milk formula containing hydrolysed proteins. Recovery of immunoglobulin 
values and clinical resolution were achieved. Hypogammaglobulinaemia 
during early childhood in some children may be secondary to cow milk 
allergy, and immunoglobulins and cells may leak through the inflamed 
mucosa. Resolution of symptoms as well as normalization of immuno­
globulin values may be easily achieved by avoidance of the offending 
allergen.
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Introduction
Hypogammaglobulinaemia is defined as diminished levels 
of one or more immunoglobulin isotypes to values 2 SD 
below the mean estimated for age. The condition can be 
congenital (due to a primary genetic deficiency), acquired 
(secondary to an underlying disease) or physiological 
(due to an immature immune system).1’2
Physiological hypogammaglobulinaemia occurs between 
3 and 6 months of age and is a consequence of the rapid 
catabolism of the transplacentally acquired maternal 
immunoglobulin G (IgG) during this period, not com­
pensated by self-production of IgG by the lactating infant. 
When this situation persists beyond 6 months of age, the 
condition is called transient hypogammaglobulinaemia of 
infancy. It is characterized by reduced IgG levels and it 
can be accompanied by diminished IgA levels and pre­
served functional antibody response. It can be asympto­
matic or present with recurrent infections, bronchiolitis, 
bronchitis, acute median otitis, diarrhoea and, less 
frequently, pneumonia or invasive diseases.1’3 Usually, 
this clinical picture resolves spontaneously by 2 years of 
age, but in some children normalization of immuno­
globulin serum levels may occur at 4-5 years of age. 
Treatment is symptomatic and rarely requires replacement 
therapy with intravenous gammaglobulin.1’2 Transient 
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hypogammaglobulinaemia has been linked to immaturity 
of the infant immune system associated with the mucosal 
barrier (low intestinal proteolytic activity, low acid secre­
tion, immature microvillus membrane, absence of IgA 
and IgM from exocrine secretions, low concentration of 
IgA in intestine, reduced T helper type 1 lymphocyte 
function and diminished interferon-y production, etc.).4’5
The immature immune system associated with the 
gastrointestinal mucosa is confronted with foreign pro­
teins such as bacteria and food antigens. The normal 
healthy gut exhibits tolerance both to beneficial dietary 
antigens and to innocuous antigens derived from com­
mensal flora, but will mount active and protective 
immune responses against damaging antigens from inva­
ding gut pathogens. When such immune control mech­
anisms do not work properly, the consequences can be 
devastating. Loss of tolerance to food antigens can 
manifest as food allergies, while loss of tolerance to the 
luminal commensal flora contributes to the development 
of inflammatory bowel disease. In any case the gut epi­
thelial barrier does not separate the luminal contents 
from the mucosal immune system and the passage of 
antigens is inappropriately regulated. Gut epithelial bar­
rier dysfunction could allow luminal antigens to enter 
the lamina propria and plasma proteins and cells to 
leak into the lumen.6
Certain food and inhalatory allergens induce a sensiti­
zation state that can lead to a clinical picture of intoler­
ance or allergy. Since the intestinal mucosa receives most 
of the antigen load, food allergy may present within a few 
weeks after the initial intake of cows’ milk (CM) or 
maternal milk.7 The most affected organs are the skin 
and the intestinal and respiratory mucosae.8 A persistent 
involvement of these mucosae can be accompanied by 
protein loss through faeces or through extensive cutane­
ous lesions, leading to hypogammaglobulinaemia.2’9
Thirty-four patients less than 2 years of age and with 
different clinical pictures associated with hypogamma­
globulinaemia were studied during 2004—2005. Once a 
primary immunodeficiency (PID) was ruled out (32/34), 
a hypogammaglobulinaemia secondary to protein loss was 
considered, and cow milk allergy (CMA) was suspected 
based on the clinical picture. Ten patients showed clinical 
signs of atopy and positive specific IgE antibodies. In five 
of the 10 patients protein loss through the mucosa was 
suspected. Cow milk was removed from the diet as a 
therapy, leading to resolution of symptoms as well as 
normalization of immunoglobulin values.
Materials and methods
Subjects
During 2004-2005, 34 patients younger than 2 years of 
age with hypogammaglobulinaemia were studied. They 
showed clinical signs of diarrhoea, infections and eczema 
and were referred to the Immunology Service to investi­
gate a possible PID. In two of them PID was diagnosed, 
while in the remaining 32 subjects immunoglobulin levels 
were lower than normal according to age, and they 
showed a normal antibody function. Ten out of the 32 
patients showed CM-specific IgE antibodies. Five patients 
(aged 4—18 months, two females and three males) with 
hypogammaglobulinaemia (serum immunoglobulin levels 
1 SD or 2 SD below the mean value for age) suffered 
chronic diarrhoea (four of the five), bronchoconstriction 
(three of the five) and severe eczema (one of the five). 
These patients were thoroughly studied in this work 
because we hypothesized that there was likely protein loss 
occurring through the mucosa.
al-Antitrypsin clearance
Levels of al-antitrypsin were measured by radial immuno­
diffusion (DAKO Denmark, Glostrup, Denmark) in faecal 
samples, collected throughout 48 hr, and in serum samples. 
Values lower than 12-5 ml/24 hr were considered normal.
Immunoglobulin measurement
Total serum immunoglobulin levels were measured by 
nephelometry using commercially available kits (Beckman 
Immunochemistry Systems; IgM, IgG and IgA; Beckman 
Coulter Inc., Fullerton, CA). Specific antibody production 
was not evaluated. An Array 360 System (Beckman Coulter 
Inc., Fullerton, CA) was used.
Humoral immune response analysis
The capacity of the immune system to respond to specific 
stimuli was assessed through the administration of tet­
anus toxoid vaccine. The presence of specific antitetanus 
antibodies in serum was investigated 20 days later, using 
an indirect enzyme-linked immunosorbent assay (ELISA). 
A serum sample obtained at the moment of vaccination 
was assessed in parallel.
Analysis of peripheral cell subsets
Peripheral blood mononuclear cells from heparinized 
venous blood of patients were isolated on Ficoll-Hypaque 
gradients (Histopaque-1077, Sigma Chemical Co., St. 
Louis, MO), and different cell subsets were analysed by 
multiparametric flow cytometry in a FACScan (Becton 
Dickinson, San Jose, CA). Cells were stained for various 
surface markers by incubation with specific conjugated 
monoclonal antibodies (Becton Dickinson): anti-CD3 
peridinin chlororphyll protein (PerCP; SK3), anti-CD4 
fluorescein isothiocyanate (FITC; SKI), anti-CD8 phyco­
erythrin (PE; SK7), anti-CD20 PE (B73.1), anti-CD56 
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PE (NCAM 16.2). The respective isotype controls were 
performed.
In vitro lymphocyte proliferative responses to mitogens
Isolated peripheral blood mononuclear cells were cultured 
in microtitre plates with culture medium (RPMI-1640) 
supplemented with 10% fetal calf serum and antibiotics. 
Cells were grown at 37° with 5% CO2. Cells (1 X 105 per 
well) were stimulated for 72 hr with different mitogens: 
phytohaemagglutinin (PHA; 8 Ltg/ml), pokeweed mitogen 
(PWM; 2 pg/ml), phorbol 12-myristate 13-acetate (PMA)/ 
Ionomycin (Io) (0-87 pg/ml), concanavalin A (Con A; 
2 Ltg/ml), OKT3 (engineered monoclonal antibody to the 
T3 antigen of human T cells; 1 Ltg/ml). The cells were 
pulsed for the last 17 hr with 1 pCi/well [3H] thymidine. 
Radioactivity incorporated into cellular DNA was meas­
ured in a P scintillation counter.
Serum IgE measurement
Total IgE and CM-specific IgE were measured using cap­
ture ELISA and enzyme allegro sorbent test, respectively.10
Skin test
In vivo specific IgE was evaluated by skin prick tests on 
the anterior surface of the forearm using commercial 
extracts of whole cow milk (IgCenter, Buenos Aires, 
Argentina), in parallel with control solutions of buffered 
saline and histamine chlorhydrate (10 mg/ml). The wheals 
were measured after 15 min. Patients with skin reactions 
at least 3 mm greater than the negative control were 
defined as positive.
Coeliac disease serology
Screening methods for coeliac disease were used. IgG and 
IgA antibodies against tissue transglutaminase were meas­
ured by an indirect ELISA using recombinant human 
transglutaminase (Biosystems SA, Barcelona, Spain). Anti- 
endomysial IgG and IgA antibodies were assessed by indi­
rect immunofluorescence assay using commercial slides of 
monkey oesophagus sections (INOVA Diagnostic Inc., 
San Diego, CA).
Tissue specimens
Duodenal mucosal samples were obtained by biopsy during 
endoscopic examination, and specimens were processed for 
routine histological examination with standard formalin 
fixation and paraffin embedding. Sections were stained 
with haematoxylin 8< eosin to establish the villus : crypt 
ratio and the presence of cellular infiltrates.
Results
The age of symptom onset ranged between 2 days and 
18 months. All the patients were seen in the Immunology 
Service with a presumptive diagnosis of PID based on the 
presence of different clinical signs associated with a clin­
ical picture of hypogammaglobulinaemia.
Patient 1 (GV, aged 11 months) presented with chronic 
diarrhoea and treatment-resistant recurrent bronchiolytic 
syndrome leading to several hospitalizations. Both mal­
absorption syndrome and cystic fibrosis were ruled out. A 
family history of atopy was recorded. At the first visit the 
patient had reduced IgG levels (Table 1), increased levels 
of total IgE and CM-specific IgE, and a positive prick test 
(Table 2). al-Antitrypsin clearance was 15-6 ml/24 hr. 
Seven months after elimination of CM from the diet, 
serum immunoglobulin levels were normal (Table 1) and 
the patient had a favourable clinical course with resolu­
tion of diarrhoea and bronchoconstriction.
Patient 2 (CF, 18 months) presented with chronic diar­
rhoea secondary to a viral gastrointestinal infection. This 
patient required a prolonged hospitalization because of a 
severe hypoalbuminaemia accompanied by generalized 
oedema. Serum immunoglobulin levels were measured, 
and a severe hypogammaglobulinaemia involving the




Immunoglobulin level before treatment Immunoglobulin level after treatment
IgG1 IgA IgM IgG IgA IgM
GV 11 5042 (935 ± 346) 27 (47 ± 29) 78 (120 ± 44) 804 (1094 ± 358) 67 (86 ± 48) 124 (119 ± 36)
CF 18 1023 (1094 ± 358) 122 (86 ± 48) 303 (119 ± 36) 4503 (1089 ± 259) 272 (86 ± 48) 592 (105 ± 26)
CL 3 1393 (555 ± 132) 10 (22 ± 15) 46 (59 ± 41) 4892 (935 ± 346) 132 (47 ± 29) 76 (120 ± 44)
RI 8 5382 (935 ± 346) 57 (47 ± 29) 86 (120 ± 44) 766 (935 ± 346) 42 (47 ± 29) 662 (120 ± 44)
MF 10 4862 (935 ± 346) 72 (47 ± 29) 115 (120 ± 44) 5642 (1094 ± 358) 92 (86 ± 48) 101 (119 ± 36)
NV normal value.
2Immunoglobulin level 1SD lower than mean for age. 
immunoglobulin level 2 SD lower than mean for age. 
AAT, al-antitrypsin: normal value <12 ml/24 hr.
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GV 3 167 2 15-6
CF 0 104 1 18-5
CL ND 551 2 3-3
RI 4 106 2 18-2
MF ND 118 3 18-2
Positive prick test: papule-erythema diameter > 3 mm. ND, not done. 
2Normal values for total IgE: lower than 60 IU/ml.
3CM-specific IgE: class 0, negative; classes 1-4, positive.
AAT clearance, 71 antitrypsin clearance. Normal value: < 12 ml/24 hr.
three isotypes (IgG, IgA, IgM) was detected. The study of 
peripheral cell subpopulations revealed a CD4+ T-cell 
lymphopenia and diminished cellular function. Histologi­
cal examination of intestinal biopsies revealed a grade II 
enteropathy (widened villi in the duodenal mucosa, abun­
dant enterocytes, preserved microvilli, lamina propria 
oedema, plasma cell infiltrate, and occasional eosinophil 
infiltrate). Coeliac disease serology was negative. The 
al-antitrypsin clearance was 18-5 ml/24 hr. Parenteral 
feeding led to clinical improvement. A subsequent immu­
nological evaluation revealed a marked improvement of 
serum levels of immunoglobulins, and normalization of 
lymphocyte subpopulations and of functional humoral 
and cellular immune responses, which led us to rule out 
a primary immunodeficiency. A second intestinal biopsy 
revealed mild oesophagitis, moderate to severe entero­
pathy, unspecific colitis (oesophagitis in the lower third, 
pale and oedematous gastric mucosa, duodenitis, vascular 
pattern, and pale, oedematous and friable colonic 
mucosa). Addition of CM to the diet worsened the diar­
rhoea and the generalized oedema, leading to re-hospital- 
ization. Faecal protein loss was demonstrated by an 
increased al-antitrypsin clearance. Since intolerance to 
cow milk proteins (CMP) was suspected, CM-specific IgE 
antibodies were measured and prick tests were performed 
(Table 2). Avoidance of CM was indicated because speci­
fic IgE antibodies as well as high levels of serum total IgE 
were detected. Complete restriction of CM allowed 
the patient to recover. Immunoglobulin levels after 
10 months of diet exclusion are shown in Table 1.
Patient 3 (CL, 3 months) was referred with severe 
eczema involving 100% of the body surface. Immuno­
globulin levels were measured to rule out a combined 
immunodeficiency, and reduced levels of IgG were found 
(more than 2 SD below the mean for age) (Table 1). The 
patient had been fed with infant formula since birth, and 
had presented with seborroeic eczema in the scalp within 
the first 24 hr of life, which evolved to a generalized 
severe atopic dermatitis at 20 days. Weight and height 
showed adequate progress and the patient did not suffer 
severe infections. Immunological studies revealed func­
tional antibodies, normal leucocyte count, and lympho­
cyte populations within normal percentages for age. The 
generalized skin involvement and the early age led to sus­
picions of an alimentary allergy to CMP. Therefore, total 
IgE and CM-specific IgE were measured (Table 2). The 
generalized cutaneous involvement precluded the execu­
tion of skin tests. The clearance of al-antitrypsin was 
normal (3-3 ml/24 hr). Taking into account the presence 
of serum-specific IgE and the clinical picture consistent 
with CMA, CM was eliminated from the patient’s diet 
and was replaced with infant milk formula containing a 
hydrolysed protein. This led to a marked improvement of 
symptoms and serum immunoglobulins. At the 1 year 
follow-up, the clinical picture of the patient showed con­
tinued favourable progress. In Table 1 immunoglobulin 
levels before and after 5 months of CM exclusion diet are 
shown.
Patient 4 (RI, 12 months) had recurrent respiratory 
infections and chronic diarrhoea. As shown in Table 1, 
serum immunoglobulin measurement revealed diminished 
IgG levels, a good functional antibody response, and lym­
phocyte subsets within normal percentages for age. Total 
IgE levels were increased for age, and CM-specific IgE 
antibodies were detected. In addition, the skin test was 
positive for CMP (Table 2). The clearance of al-antitryp- 
sin was 18-2 ml/24 hr. This patient was usually breastfed, 
and the clinical signs resolved when his mother started a 
CMP-free diet. He was also indicated to avoid CM inges­
tion and after a 3-month period of diet exclusion the 
serum IgG level was normalized.
Patient 5 (MF, 10 months) had ponderal growth retar­
dation and a history of chronic diarrhoea and recurrent 
bronchial obstruction associated with hypochromic 
microcytic anaemia. Serum immunoglobulin measure­
ments (Table 1) revealed diminished levels of IgG and 
IgA. Total IgE level was increased and CM-specific IgE 
was detected. The clearance of al-antitrypsin was 18-2 ml/ 
24 hr. Since CMA was suspected, an exclusion diet was 
indicated, which led to a marked clinical improvement. As 
depicted in Table 1 immunoglobulin levels showed a slight 
recovery after 6 months of CM exclusion.
The response to tetanus toxoid was normal in all 
patients (normal value 0-1 IU/ml). Lymphocyte prolifer­
ation assays with mitogens and cell subset analyses were 
normal in four patients. Only one patient (Patient 2) had 
a low number of CD4+ T cells shown by flow cytometry, 
and also had decreased lymphoproliferative response to 
PHA, Con A, PWM and PMA/Io. Serological tests for 
coeliac disease were negative in all patients (anti-endo- 
mysial and anti-transglutaminase IgG and IgA). Duodenal 
biopsy was performed in patients FC and RI because they 
showed more severe clinical manifestations. Histological 
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analyses revealed non-specific alterations, and coeliac dis­
ease was ruled out. No patient had human immunodefi­
ciency virus-specific IgG antibodies.
Discussion
Cow milk allergy is one of the most common food aller­
gies in childhood and constitutes a pathological condition 
in which the recognition of CMP in the intestinal mucosa 
is altered. About half of the immunological responses to 
food are IgE-mediated8’11 and it has become evident that 
allergen-specific T helper type 2 cells play a central role in 
the genesis and maintenance of the allergic inflammatory 
reactions in both human subjects and mouse models.12’13 
Factors responsible for the polarization of the specific 
immune response to a predominant T helper type 2 
response in atopic subjects and laboratory animals remain 
undefined. Both environmental and genetic factors may 
influence the differentiation of T cells from a common 
precursor. Functional and phenotypic differences in sub­
classes of dendritic cells14’15 and epithelial cells16’17 
between allergic and non-allergic donors have been repor­
ted. These cells may be involved in the abnormal activa­
tion of T cells against innocuous antigens.
The diagnosis of CMA is based on the family and per­
sonal history, complementary in vivo and in vitro tests 
and the double-blind placebo-controlled food challenge 
(DBPCFC), which is considered the confirmatory stand­
ard test.18 Although the DBPCFC is 100% specific, it is 
time-consuming and may elicit undesirable reactions in 
positive challenges. In addition, life-threatening anaphy­
lactic reactions may occur in patients with a previous his­
tory of severe reactions.19 The DBPCFC is not performed 
in Argentina; the screening includes only an elimination 
diet.
Immunoglobulin synthesis begins immediately after 
birth in response to colonization of the gastrointestinal 
tract, infections and other antigenic stimulation. This 
reciprocal interaction between the intestinal microbiota, 
mainly commensal microbes, and the mucosal immune 
system may contribute to immune disorders, such as 
allergies and inflammatory bowel disease.20 In this con­
text, the intestinal microbiota and the integrity of the 
intestinal barrier are relevant for the appropriate develop­
ment of the B-lymphocyte repertoire. PID arises as a 
consequence of failures in some of the immunological 
mechanisms involved in these complex processes. In the 
last 10 years, as a result of greater knowledge of their 
pathogenesis and with the implementation of more mod­
ern and accurate laboratory tests, different clinical condi­
tions have been identified.1’3’21 Although numerous 
pathogenic mechanisms have been proposed, the cause 
of the transient hypogammaglobulinaemia of infancy 
remains unknown.22 A delayed maturation of B-cell func­
tion23 defects in T helper cell maturation24 or cytokine 
imbalance25’26 may underlie the impaired synthesis of 
antibodies. On the other hand, secondary immunodefi­
ciencies exhibit similar clinical pictures and can be caused 
by very diverse processes (onco-haematological, metabolic 
or infectious diseases, malnutrition, etc.).9’27
The Argentinean Society for Paediatrics (SAP) pub­
lished the PID registry for the 1994-1999 period.28 It 
included 652 immunodeficiency cases, of which 489 
(75%) were humoral deficiencies. In 137 cases (28%) the 
diagnosis was established before the age of 2 years. Tran­
sient hypogammaglobulinaemia of infancy was diagnosed 
in 26 patients. In 2004 an internal SAP bulletin reported 
1240 cases of PID, of which 871 (70%) corresponded to 
humoral immunodeficiencies (unpublished data).
In the current study patients showed a symptomatic 
hypogammaglobulinaemia and were referred to the 
Immunology Service with clinical signs consistent with an 
early manifestation of a primary immunodeficiency. Once 
PID was ruled out, the hypogammaglobulinaemia was 
considered to be secondary to other conditions. Food 
allergy was documented by history and elevated serum 
IgE levels. We suspected that in five patients the hypo­
gammaglobulinaemia was the consequence of protein loss 
through the skin or the gut.
Patient 1 (GV), while having a clinical picture suggest­
ive of CMA, had a strong family history of allergic dis­
ease. Her parents had atopic disease and she had a 
4-year-old-sister with CMA diagnosed at the age of 
10 months. Her sister had been treated with an exclusion 
diet up to the age of 2 years, and two years later she was 
diagnosed a coeliac disease. The coexistence of coeliac dis­
ease and CMA has been previously reported.29 Patient 2 
(CF) was the only one presenting with lymphopenia, 
which was probably associated with the hypogammaglob­
ulinaemia. This deficiency was severe and included the 
three immunoglobulin isotypes measured. The damaged 
gut mucosa and the augmented clearance of al-antitryp- 
sin led us to consider that the diminished serum levels of 
immunoglobulins and albumin could result from protein 
loss through stools. The loss of IgM would reflect a severe 
intestinal involvement, because this protein has a high 
molecular weight. The presence of acute malnutrition 
during the initial phase of the disease masked the diagno­
sis. The diminished functional cellular response in the 
first assessment was linked to the acute loss of lympho­
cytes and nutrients.2’9’27 After 10 months of CM-free diet, 
the patient exhibited a marked improvement in the serum 
level of immunoglobulins. Patient 3 (CL) had an import­
ant cutaneous reaction, possibly as a result of her atopic 
condition. It is usually assumed that IgG loss occurs 
mainly through skin. After the initiation of treatment the 
eczema improved and the serum IgG level recovered 
thereafter. It is widely described that some of the most 
common clinical manifestations of CMA are the cutane­
ous reactions, mainly atopic dermatitis.30’31 Patient 4 (RI) 
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had a strong family history of systemic diseases (atopy, 
rheumatoid arthritis, coeliac disease). Family history dis­
closed an atopic mother affected by rheumatoid arthritis, 
a cousin with coeliac disease and an aunt affected by sys­
temic lupus erythematosus. Latcham et al. reported fam­
ilial history of autoimmune diseases (systemic lupus 
erythematosus, rheumatoid arthritis, thyroiditis, etc.) in 
30% of children suffering CMA.32 A relationship with 
food allergy was clear in Patient 5 (MF) because she pre­
sented with progressive reduction of weight and insignifi­
cant increase in height, and had clinical gastrointestinal 
and pulmonary signs. A CM exclusion diet also led to 
clinical improvement and serum immunoglobulin recov­
ery. Regarding IgE antibodies, all the patients studied 
exhibited high levels of total and specific IgE. Skin prick 
tests could only be performed in three patients, two of 
whom had positive results. The absence of a skin response 
to allergens could relate to the low age of the patients.33’34 
Although specific IgE to CMP was detected in all our 
patients, it must be kept in mind that the absence of 
these antibodies does not rule out an allergic process. 
A marked improvement in clinical and laboratory para­
meters after allergen restriction is a strong indicator of 
this entity, which is further confirmed by an immediate 
reappearance of the clinical picture upon a new inclusion 
of the offending allergen. The complete recovery of the 
IgA level after treatment may be delayed. The effect of 
the exclusion diet treatment may lie on the retrieval of 
the mucosal integrity. IgA antibodies are mainly produced 
by B cells from the lamina propria and the commensal 
flora should be restored to achieve the homeostasis of the 
gut mucosa.
Fineman et al. have reported that hypogammaglobulin­
aemia associated with elevated IgE level and food allergy 
may be secondary to a decreased production of antibod­
ies. This study included four patients younger than 
2 years of age and gastrointestinal protein loss was not 
detected. The authors hypothesized that T-cell-dependent 
B-cell activation was impaired. All patients were treated 
with intramuscular gammaglobulin and had a diet free of 
the suspected allergen. Both recovery of immunoglobulin 
values and clinical resolution were achieved.23 Walker 
et al. found that a significant proportion of children with 
hypogammaglobulinaemia suffered food allergy. They 
suggested that the allergen-induced gastrointestinal 
inflammation might be a contributing factor to the pro­
tein loss from the bowel. They found normal number and 
function of lymphocytes, thus ruling out a deficiency of T 
helper cells.35 Kilic et al. also described hypogammaglobu- 
linaemic patients with allergic symptoms (mainly bron­
chial asthma and atopic dermatitis), with a normal 
capacity to synthesize specific antibodies in response to 
immunization. Patients needed replacement therapy with 
intravenous immunoglobulin to recover the immunoglob­
ulin levels.36 Kidon et al. also reported a high prevalence 
of atopic manifestations in patients with symptomatic 
hyp ogammaglobulinaemia.3 7
In summary, CMA, which can be easily treated, must 
be suspected in children with clinical signs of atopy and a 
clinical picture and laboratory findings consistent with 
PID, once this latter condition and other underlying dis­
eases have been ruled out. On the other hand, transient 
hypogammaglobulinaemia should lead the physician to 
suspect a secondary condition associated with protein loss 
in children with diarrhoea. The al-antitrypsin clearance 
is a significant marker of mucosal integrity and consti­
tutes the first evidence of protein loss.2’9
Although we have found a 14-7% association between 
hypogammaglobulinaemia and protein loss as a conse­
quence of CMA, more patients will be included in the 
study to estimate the prevalence of this condition.
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